ロード中...

TMIC-26. IMMUNOMODULATION WITH TEMOZOLOMIDE TO IMPROVE EFFICACY OF IMMUNE CHECKPOINT INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA

Immune checkpoint inhibitors are under active investigation as novel strategies for the treatment of newly diagnosed glioblastoma (GBM). Due to the effects of temozolomide (TMZ) on host immunity, we hypothesize that dose and timing of TMZ will impact efficacy of immune checkpoint inhibition with PD-...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Karachi, Aida, Dastmalchi, Farhad, Yang, Changlin, Huang, Jianping, Mitchell, Duane, Rahman, Maryam
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692988/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1015
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!